Sign in to continue:

Tuesday, April 14th, 2026

Author: Minichart

us corporate news

Arvinas, Inc. Reports Forward-Looking Statements and Updates on ARV-102 Neurodegenerative Disease Program – March 2026

Minichart
March 18, 2026

Arvinas Announces Positive Phase 1 Data for ARV-102 in Parki...

Continue Reading 0
us corporate news

InspireMD Reports 62% Q4 Revenue Growth and Sets 2026 Outlook for CGuard Prime Carotid Stent System

Minichart
March 18, 2026

InspireMD Reports Strong Q4 and Full Year 2025 Results: Subs...

Continue Reading 0
us corporate news

SailPoint Reports 28% ARR Growth to $1.125 Billion in Fiscal Year 2026, Driven by Strong SaaS Performance

Minichart
March 18, 2026

SailPoint, Inc. Fiscal 2026 Full Year and Q4 Financial Resul...

Continue Reading 0
us corporate news

Tecnoglass Declares $0.15 Quarterly Dividend for Q1 2026, Payable April 30

Minichart
March 18, 2026

Tecnoglass Announces First Quarter 2026 Dividend Tecno...

Continue Reading 0
us corporate news

EDAP TMS S.A. Leads Global Growth in Robotic HIFU for Prostate Cancer with Strong Clinical Evidence and Reimbursement 910111213141516

Minichart
March 18, 2026

EDAP TMS S.A. Presents at Oppenheimer 36th Annual Healthcare...

Continue Reading 0
us corporate news

Spire Global Reports Strong Q4 and Full Year 2025 Results with Improved Financials and Satellite Launches

Minichart
March 18, 2026

Spire Global, Inc. Reports Q4 and Full Year 2025 Results: Ke...

Continue Reading 0
us corporate news

Jabil Reports Strong Q2 2026 Results, Raises Full-Year Outlook and Delivers Robust Core EPS and Revenue Growth

Minichart
March 18, 2026

Jabil Inc. Q2 2026 Financial Results: Detailed Report for In...

Continue Reading 0
us corporate news

McCormick & Company 8-K Filing March 12, 2026: Common Stock Details, NYSE Listings, and Company Information

Minichart
March 18, 2026

McCormick & Co Inc. 8-K Filing: Detailed Investor Report ...

Continue Reading 0
us corporate news

Ovid Therapeutics Expands OV329 Epilepsy Program, Launches Phase 1 OV4071 Trial, and Reports Strong 2025 Financial Results

Minichart
March 18, 2026

Ovid Therapeutics Announces Major Pipeline and Financial Mil...

Continue Reading 0
us corporate news

Incannex Highlights $75 Million Cash, No Debt, and Advances IHL-42X and PSX-001 Clinical Programs

Minichart
March 18, 2026

Incannex Healthcare Highlights Strong Financial Position and...

Continue Reading 0